Cargando…

Nurse-like cells impact on disease progression in chronic lymphocytic leukemia

Detalles Bibliográficos
Autores principales:	Boissard, F, Laurent, C, Ramsay, A G, Quillet-Mary, A, Fournié, J-J, Poupot, M, Ysebaert, L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742625/ https://www.ncbi.nlm.nih.gov/pubmed/26771807 http://dx.doi.org/10.1038/bcj.2015.108

Ejemplares similares

Nurse-like cells mediate ibrutinib resistance in chronic lymphocytic leukemia patients
por: Boissard, F, et al.
Publicado: (2015)

Nurse-like cells promote CLL survival through LFA-3/CD2 interactions
por: Boissard, Frédéric, et al.
Publicado: (2016)

3R gene expression in chronic lymphocytic leukemia reveals insight into disease evolution
por: Grgurevic, S, et al.
Publicado: (2016)

Obinutuzumab (GA101) is highly effective against chronic lymphocytic leukemia cells in ex vivo B-cell depletion irrespective of high-risk prognostic markers
por: Ysebaert, L, et al.
Publicado: (2015)

An agent-based model of monocyte differentiation into tumour-associated macrophages in chronic lymphocytic leukemia
por: Verstraete, Nina, et al.
Publicado: (2023)

Idelalisib improves CD37 antibody BI 836826 cytotoxicity against chemo-resistant /relapse-initiating CLL cells: a rationale for combination treatment
por: Betrian, S, et al.
Publicado: (2016)

IL-10 Rescues CLL Survival through Repolarization of Inflammatory Nurse-like Cells
por: Domagala, Marcin, et al.
Publicado: (2021)

Longitudinal CITE-Seq profiling of chronic lymphocytic leukemia during ibrutinib treatment: evolution of leukemic and immune cells at relapse
por: Cadot, Sarah, et al.
Publicado: (2020)

Functional assessment of p53 in chronic lymphocytic leukemia
por: Le Garff-Tavernier, M, et al.
Publicado: (2011)

DNA polymerase ν gene expression influences fludarabine resistance in chronic lymphocytic leukemia independently of p53 status
por: Grgurevic, Srdana, et al.
Publicado: (2018)

Cancer Stem Cells of Differentiated B-Cell Malignancies: Models and Consequences
por: Gross, Emilie, et al.
Publicado: (2011)

Subtotal splenectomy for the treatment of chronic lymphocytic leukemia
por: Petroianu, A
Publicado: (2015)

Lymphoma Heterogeneity Unraveled by Single-Cell Transcriptomics
por: Ysebaert, Loic, et al.
Publicado: (2021)

APOBEC3 signature mutations in chronic lymphocytic leukemia
por: Rebhandl, S, et al.
Publicado: (2014)

Fatal Algaemia in Patient with Chronic Lymphocytic Leukemia
por: Lanotte, Philippe, et al.
Publicado: (2009)

The Coexistence of Chronic Lymphocytic Leukemia and Multiple Myeloma
por: Hangül, Ceren, et al.
Publicado: (2019)

The gut microbiome in patients with chronic lymphocytic leukemia
por: Faitová, Tereza, et al.
Publicado: (2022)

MiR-155/miR-150 network regulates progression through the disease phases of chronic lymphocytic leukemia
por: Vargova, K, et al.
Publicado: (2017)

Serum monoclonal component in chronic lymphocytic leukemia: baseline correlations and prognostic impact
por: Mozas, Pablo, et al.
Publicado: (2020)

A Case of Acute Myeloid Leukemia Concurrent With Untreated Chronic Lymphocytic Leukemia
por: Lee, Hye-Young, et al.
Publicado: (2017)

Chronic Lymphocytic Leukemia with Dermatomyositis: A Therapeutic Challenge
por: Kumar, Sudhir, et al.
Publicado: (2020)

Ibrutinib-Induced Cardiac Tamponade in Chronic Lymphocytic Leukemia
por: Kidoguchi, Keisuke, et al.
Publicado: (2021)

Acalabrutinib in Membranous Nephropathy Associated With Chronic Lymphocytic Leukemia
por: Izzedine, Hassan, et al.
Publicado: (2022)

Mechanisms and consequences of the loss of PHLPP1 phosphatase in chronic lymphocytic leukemia (CLL)
por: O'Hayre, M, et al.
Publicado: (2012)

Non-coding NOTCH1 mutations in chronic lymphocytic leukemia; their clinical impact in the UK CLL4 trial
por: Larrayoz, M, et al.
Publicado: (2017)

Sporadic and reversible chromothripsis in chronic lymphocytic leukemia revealed by longitudinal genomic analysis
por: Bassaganyas, L, et al.
Publicado: (2013)

Capnocytophaga sputigena Bacteremia in a Patient with Chronic Lymphocytic Leukemia
por: Kim, Jung-Ah, et al.
Publicado: (2014)

Chronic lymphocytic leukemia with massive ascites: An unusual presenting manifestation
por: Gogia, Ajay, et al.
Publicado: (2014)

Chronic lymphocytic leukemia with deletion 17p: An Indian scenario
por: Gogia, Ajay, et al.
Publicado: (2019)

First Case of Transformation of Immunoglobulin Heavy Chain Variable-Mutated Chronic Lymphocytic Leukemia Into Chronic Myeloid Leukemia
por: Zhang, Xueya, et al.
Publicado: (2019)

Ibrutinib in previously treated chronic lymphocytic leukemia patients with autoimmune cytopenias in the RESONATE study
por: Montillo, M, et al.
Publicado: (2017)

Low expression of ZHX1 and ZHX2 impacts on the prognosis of chronic lymphocytic leukemia
por: Maciel, Natália Ioseph Gladistone, et al.
Publicado: (2021)

Comparative analysis of targeted novel therapies in relapsed, refractory chronic lymphocytic leukemia
por: Eyre, Toby A., et al.
Publicado: (2020)

Subclonal evolution involving SF3B1 mutations in chronic lymphocytic leukemia
por: Schwaederlé, M, et al.
Publicado: (2013)

Spontaneous tumor lysis syndrome in a patient of chronic lymphocytic leukemia
por: Gogia, Ajay, et al.
Publicado: (2014)

Paraneoplastic pemphigus with anti-desmocollin 3 autoantibodies and chronic lymphocytic leukemia
por: Adaszewska, Alicja, et al.
Publicado: (2018)

MDM2 Oncogene Copy Number Alterations in Chronic Lymphocytic Leukemia
por: Sookaromdee, Pathum, et al.
Publicado: (2019)

Expression and function of cathelicidin hCAP18/LL-37 in chronic lymphocytic leukemia
por: Podaza, Enrique, et al.
Publicado: (2020)

Common variation at 12q24.13 (OAS3) influences chronic lymphocytic leukemia risk
por: Sava, G P, et al.
Publicado: (2015)

Differential expression, localization and activity of MARCKS between mantle cell lymphoma and chronic lymphocytic leukemia
por: Vargova, J, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8kkbnq1dfg6v2qchh22umacfdp